1. Home
  2. UBCP vs ELTX Comparison

UBCP vs ELTX Comparison

Compare UBCP & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Bancorp Inc.

UBCP

United Bancorp Inc.

N/A

Current Price

$15.46

Market Cap

91.6M

Sector

Finance

ML Signal

N/A

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$2.72

Market Cap

81.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UBCP
ELTX
Founded
1902
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.6M
81.2M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
UBCP
ELTX
Price
$15.46
$2.72
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$18.00
AVG Volume (30 Days)
1.6K
255.7K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
5.73%
N/A
EPS Growth
5.51
39.29
EPS
0.69
N/A
Revenue
N/A
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.58
N/A
P/E Ratio
$22.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.47
$2.66
52 Week High
$17.34
$16.00

Technical Indicators

Market Signals
Indicator
UBCP
ELTX
Relative Strength Index (RSI) 47.19 33.30
Support Level $14.97 N/A
Resistance Level $16.10 $3.32
Average True Range (ATR) 0.31 0.13
MACD 0.01 0.04
Stochastic Oscillator 15.07 0.74

Price Performance

Historical Comparison
UBCP
ELTX

About UBCP United Bancorp Inc.

United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which include accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. The Company's primary deposit products are checking, savings, and term certificate accounts, and its primary lending products are residential mortgage, commercial, and installment loans. The bank also operates in Marshall County, West Virginia.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: